透明细胞组织学预示WHO II级脑膜瘤预后更差
该回顾性研究比较了透明细胞脑膜瘤(CCM)与其他WHO II级脑膜瘤的生存差异,纳入1997至2019年214例手术患者(43例CCM,171例其他II级)。CCM的无进展生存(p=0.001)和总生存(p=0.026)均显著更短,多变量分析显示透明细胞组织学是肿瘤复发的独立预测因子(HR 1.93;95%CI 1.14-3.26)。
要点
- 透明细胞脑膜瘤较其他WHO II级脑膜瘤复发风险显著更高。
- 透明细胞组织学是肿瘤复发的独立预测因子(HR 1.93)。
- 透明细胞组织学与死亡风险增加相关但未达统计学显著(HR 1.96)。
核心结论
- 透明细胞组织学预示比其他WHO II级组织学更高的肿瘤复发和死亡风险。
研究设计与样本
- 回顾性机构数据库审查,纳入1997至2019年接受手术切除的WHO II级脑膜瘤患者共214例(43例CCM,171例其他II级)。
主要发现
- CCM患者无进展生存显著短于其他II级脑膜瘤患者(p=0.001)。
- CCM患者总生存显著短于其他II级脑膜瘤患者(p=0.026)。
- 多变量分析中透明细胞组织学是肿瘤复发的显著独立预测因子(HR 1.93;95%CI 1.14-3.26)。
- 多变量分析中透明细胞组织学与死亡风险增加相关但无统计学显著性(HR 1.96;95%CI 0.97-3.94)。
临床怎么用
- 对透明细胞脑膜瘤患者应加强术后随访监测以早期发现复发。
局限性
- 本研究为单中心回顾性设计,结论需未来研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clear cell meningioma (CCM) is a rare WHO grade II meningioma variant, characterized by aggressive features and a high tumor recurrence rate. In this study, we compared overall and progression-free survivals between CCMs and other WHO grade II meningiomas. METHODS: A retrospective institutional database review was performed to identify all patients who underwent surgical resection of a WHO grade II meningioma between 1997 and 2019. Overall survival and progression-free survival were compared between patients with clear cell meningiomas and patients with other WHO grade II meningiomas. Multivariable Cox proportional-hazards analysis was used to identify independent predictors of tumor recurrence and survival. RESULTS: We included a total of 214 patients in this study (43 CCMs, 171 other WHO grade II meningiomas). Patients with CCMs had significantly shorter progression-free (p = 0.001) and overall (p = 0.026) survivals than patients with other grade II meningiomas. In multivariable analysis, clear cell histology was a significant and powerful independent predictor of tumor recurrence (HR 1.93; 95% CI 1.14-3.26) when controlling for tumor location, extent of resection, and adjuvant radiation. In multivariable analysis, clear cell histology correlated with increased mortality (HR 1.96, 95% CI 0.97-3.94), though this was not statistically significant. CONCLUSION: This is the first study to compare overall and progression-free survivals between CCMs and other WHO grade II meningiomas. Clear cell histology predicts a higher risk of tumor recurrence and mortality than other grade II histologies. Future studies may help to understand the impact of these findings and the treatment implications.
引用
- Soni P, Shao J, Momin A, et al. Clear cell histology portends a worse prognosis than other WHO grade II histologies. J Neurooncol. 2021. PMID: 33398533. doi:10.1007/s11060-020-03668-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。